Leggett & Platt (LEG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
22 Apr, 2026Executive summary
2025 sales were $4.05 billion, a 7% decrease year-over-year, with Q4 sales of $939 million, down 11% from Q4 2024, driven by volume declines and divestitures.
The restructuring plan launched in 2024 was substantially completed by end of 2025, delivering sustainable EBIT benefits at lower costs than expected.
Divested Aerospace business in Q3 2025, using proceeds to retire commercial paper and accelerate deleveraging, moving closer to a 2x leverage target.
Net debt leverage ratio improved to 2.4x by year-end 2025, moving closer to the long-term target of 2.0x.
Continued focus on cost structure improvements, portfolio simplification, and growth in core operations, including expansion in Specialty Foam and Automotive innovation.
Financial highlights
Q4 2025 adjusted EBIT was $48 million (5.1% margin), down $8 million year-over-year; full-year adjusted EBIT was $263 million (6.5% margin), down $4 million.
Q4 adjusted EPS was $0.22, up $0.01 year-over-year; full-year adjusted EPS was $1.05, flat versus 2024.
Operating cash flow for 2025 was $338 million, up $33 million year-over-year.
Net debt to adjusted EBITDA improved from 3.8x to 2.4x by year-end 2025.
Total debt reduced by $376 million in 2025.
Outlook and guidance
2026 sales expected at $3.8–$4.0 billion, down 1%–6% from 2025, with divestitures reducing sales by 3%.
2026 adjusted EPS guidance is $1.00–$1.20; full-year adjusted EBIT margin expected at 6.3%–7.0%.
Cash from operations projected at $225–$275 million; CapEx expected at $100–$115 million.
No macro market recovery assumed in 2026 guidance; any recovery would be upside.
Volume expected flat to down low-single digits, with raw material and currency benefits adding low-single digit growth.
Latest events from Leggett & Platt
- Q1 2026 sales and earnings fell, guidance withdrawn, and merger and market risks increased.LEG
Q1 20267 May 2026 - $2.5B all-stock acquisition expands global reach and targets $50M in annual synergies.LEG
M&A announcement14 Apr 2026 - Shareholders will vote virtually on directors, auditor, compensation, and stock plan amendments.LEG
Proxy filing7 Apr 2026 - Director elections, auditor ratification, and executive pay up for vote at 2026 annual meeting.LEG
Proxy filing7 Apr 2026 - Virtual annual meeting to vote on directors, auditor, executive pay, and stock plan amendments.LEG
Proxy filing7 Apr 2026 - Disciplined restructuring and innovation drive margin improvement and cash flow amid market headwinds.LEG
Investor presentation10 Mar 2026 - Q2 loss driven by $675M impairment, lower sales, and restructuring; dividend cut for deleveraging.LEG
Q2 20242 Feb 2026 - Sales and earnings fell, guidance cut, and restructuring, impairment, and deleveraging continue.LEG
Q3 202418 Jan 2026 - Adjusted EPS up to $0.24 despite 7% sales drop; 2025 outlook and deleveraging focus maintained.LEG
Q1 202527 Dec 2025